COVID-19 randomized controlled trials in medRxiv and PubMed

• This study investigated the difference between COVID-19 RCT in medRxiv and in PubMed. • SPIN in the conclusion was more frequently seen in reports in medRxiv than PubMed. • Readers should pay attention to the overstatements in preprints of COVID-19 RCT.

Detalles Bibliográficos
Autores principales: Kataoka, Yuki, Oide, Shiho, Ariie, Takashi, Tsujimoto, Yasushi, Furukawa, Toshi A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Federation of Internal Medicine. Published by Elsevier B.V. 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508503/
https://www.ncbi.nlm.nih.gov/pubmed/32981802
http://dx.doi.org/10.1016/j.ejim.2020.09.019
Descripción
Sumario:• This study investigated the difference between COVID-19 RCT in medRxiv and in PubMed. • SPIN in the conclusion was more frequently seen in reports in medRxiv than PubMed. • Readers should pay attention to the overstatements in preprints of COVID-19 RCT.

Ejemplares similares